This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about FERM domain-containing protein 6.
Human | |
---|---|
Gene Name: | FRMD6 |
Uniprot: | Q96NE9 |
Entrez: | 122786 |
Belongs to: |
---|
No superfamily |
FERM domain containing 6
Mass (kDA):
72.044 kDA
Human | |
---|---|
Location: | 14q22.1 |
Sequence: | 14; NC_000014.9 (51489100..51730727) |
Cytoplasm. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Can colocalize with actin.
This article will briefly review the High-affinity FRMD6 primary antibodies that are available from Steven Boster Bio as well as the FRMD6 marker, and offer some guidelines for scientists who are interested in using these antibodies. The FRMD6 marker is a molecular marker having high specificity and efficiency, has many applications in the biomedical industry. The following information is applicable to all scientists around the world.
We created a high-affinity antibody to recognize FRMD6 in human leukocytes. This antibody recognizes the Gal-1 protein in the brain as well as the ovarian cancer cell line CA125493, and the glycosamine-glycans heparansulfate and chondroitin Sulfate on human skin cells. This antibody possesses high affinity to ECM proteins such as thrombospondin, vitronectin, osteopontin, and CEA. These interactions could result in an anti-adhesive action.
The FRMD6 gene is located in the hippocampal regions, which makes it a possible candidate for AD. This gene is the first to be associated with AD that causes atrophies of the hippocampal region. Boster has provided high-affinity primary antibodies for a number of different applications, including immunohistochemistry, Western Blotting, and ELISA. The company's proprietary ELISA platform, PicoKine(tm), has been used to create high-sensitivity ELISA kits.
PMID: 16137681 by Gunn-Moore F.J., et al. A novel 4.1 ezrin radixin moesin (FERM)-containing protein, 'Willin'.